Search research articles
Contact Us
Filters
Showing results (391-400 of 594) with videos related to
Page
of 60
Sort By:
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
March 1, 1987
[Surgical treatment of aortic and tricuspid regurgitation due to infective endocarditis associated with a ventricular septal defect: a case report]
Y Sode, M Morimoto, H Yuzuriha, et al.
Oncogene
|
January 25, 2000
The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity
A M Morimoto, M G Tomlinson, K Nakatani, et al.
Anticancer Research
|
January 8, 2000
Anti-HIV-1 activity of myo-inositol hexaphosphoric acid (IP6) and myo-inositol hexasulfate(IS6)
T Otake, H Mori, M Morimoto, et al.
Blood
|
May 1, 1994
Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation
T Tsujimura, T Furitsu, M Morimoto, et al.
Experimental Hematology
|
January 1, 1995
Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor
S Adachi, T Tsujimura, T Jippo, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
November 1, 1993
[Screening test of crude drug extract on anti-HIV activity]
K Yamasaki, T Otake, H Mori, et al.
Gan
|
December 1, 1981
Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems
R Imai, M Morimoto, H Marumo, et al.
The Journal of Nutrition
|
December 1, 1995
CYP-2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet
M Morimoto, R C Reitz, R J Morin, et al.
Blood
|
January 1, 1996
Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain
T Tsujimura, M Morimoto, K Hashimoto, et al.
Journal of Medicinal Chemistry
|
January 19, 1996
2-[(2-Aminobenzyl)sulfinyl]-1-(2-pyridyl)-1,4,5,6-tetrahydrocyclopent[d]imidazoles as a novel class of gastric H+/K+-ATPase inhibitors
M Yamada, T Yura, M Morimoto, et al.
Page
of 60
Search research articles
Search
Showing results (391-400 of 594) with videos related to
Sort By:
Page
of 60
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
March 1, 1987
[Surgical treatment of aortic and tricuspid regurgitation due to infective endocarditis associated with a ventricular septal defect: a case report]
Y Sode, M Morimoto, H Yuzuriha, et al.
Oncogene
|
January 25, 2000
The MMAC1 tumor suppressor phosphatase inhibits phospholipase C and integrin-linked kinase activity
A M Morimoto, M G Tomlinson, K Nakatani, et al.
Anticancer Research
|
January 8, 2000
Anti-HIV-1 activity of myo-inositol hexaphosphoric acid (IP6) and myo-inositol hexasulfate(IS6)
T Otake, H Mori, M Morimoto, et al.
Blood
|
May 1, 1994
Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation
T Tsujimura, T Furitsu, M Morimoto, et al.
Experimental Hematology
|
January 1, 1995
Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor
S Adachi, T Tsujimura, T Jippo, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|
November 1, 1993
[Screening test of crude drug extract on anti-HIV activity]
K Yamasaki, T Otake, H Mori, et al.
Gan
|
December 1, 1981
Antitumor activity of 7-n-(p-hydroxyphenyl)-mitomycin C in experimental tumor systems
R Imai, M Morimoto, H Marumo, et al.
The Journal of Nutrition
|
December 1, 1995
CYP-2E1 inhibitors partially ameliorate the changes in hepatic fatty acid composition induced in rats by chronic administration of ethanol and a high fat diet
M Morimoto, R C Reitz, R J Morin, et al.
Blood
|
January 1, 1996
Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain
T Tsujimura, M Morimoto, K Hashimoto, et al.
Journal of Medicinal Chemistry
|
January 19, 1996
2-[(2-Aminobenzyl)sulfinyl]-1-(2-pyridyl)-1,4,5,6-tetrahydrocyclopent[d]imidazoles as a novel class of gastric H+/K+-ATPase inhibitors
M Yamada, T Yura, M Morimoto, et al.
Page
of 60